Find your path to John
367 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.
Noubar AfeyanunlockedJohn: together at Flagship Pioneering (2019–2021)
×6John: together at Flagship Pioneering
×4John: together at Drexel University
John: together at Baylor College of Medicine
About
John Pribis is a co-founder and head of business strategy at Solu Therapeutics. He has founded three companies and works at the intersection of technology and biology focused on drug development. Pribis has experience as an operator and investor in health-focused technology and biotech ventures.
Leadership at Solu
Intro paths
→
In turn, John can intro founders to Solu's investors below.
Experience
- Solu TherapeuticsCo-founder, Head of Business Strategycurrent2024 — present
- Solu TherapeuticsCo-founder and Head of BD, Strategy, and Operations2023 — 2024Boston, Massachusetts, United States
- Solu TherapeuticsCo-founder, VP of Strategy and Operations2022 — 2023Boston, Massachusetts, United States
- Longwood FundPrincipal2023Boston, MA
- Longwood FundSenior Associate2021 — 2023
- DEM Biopharma, Inc.Co-founder, VP Strategy & Operations2021 — 2022Cambridge, Massachusetts, United States
- Apriori BioCo-founder, CIO2020 — 2021
- Flagship PioneeringAssociate2019 — 2021Cambridge, MA
- Flagship PioneeringFlagship Venture Fellow2019
- Baylor College of MedicineGraduate Student2013 — 2019
- University of PittsburghDirector of Tri-Institutional Drug Discovery Program & Research Fellow2009 — 2013
Skills & more
Written CommunicationIncubationVenture CapitalBioinformatics1Research6Data Analysis4Drug Discovery3Genetic Engineering1Molecular Biology7Molecular Cloning3ProteomicsPCR6
+12 more
Cell CultureBiochemistryCell BiologyWestern BlottingGeneticsScienceLife SciencesMicroscopyMentoringTeam LeadershipJavaCLanguages English
From John's professional profile.
Network3
Aleks Radovic-Moreno
Partner at Longwood Fund
Annalisa D'Andrea
Venture Partner at Longwood Fund
David Steinberg
General Partner at Longwood Fund
Investors connected to John in public investor directories — a warm-intro map.
Frequently asked questions
- Who is John Pribis?
- John Pribis is a co-founder and head of business strategy at Solu Therapeutics. He has founded three companies and works at the intersection of technology and biology focused on drug development. Pribis has experience as an operator and investor in health-focused technology and biotech ventures.
- Where does John Pribis work?
- John Pribis is Leadership at Solu.
- What check size does John Pribis write?
- John Pribis typically writes checks of $100K – $5M.
- Where did John Pribis go to school?
- John Pribis studied at Baylor College of Medicine (Doctor of Philosophy (Ph.D.), Molecular Genetics / Antibiotic Resistance); Drexel University (BS, Biosciences).
Same school
Also attended Baylor College of Medicine40
Bret L. BostwickMD, FAAP, FACMG, Venture Advisor at Breyer CapitalNessan BerminghamInvestor at Khosla VenturesLucy LiuPrincipal at Longwood FundLovisa BackemarPartner at EIR VenturesJonathan MercadoPrincipal at First Bight VenturesCollin McCollAnalyst at First Bight Ventures
+ 34 more
Also attended Drexel University149
AdamAdvisor at Clear VenturesJesse MiddletonGeneral Partner at Flybridge Capital PartnersNabil UllahAssociate at Osage University PartnersVictoria LewisVenture Professional at Medical Excellence CapitalEliza DragomirSenior Analyst at SKY VCMarcie ReillyChief Growth Officer at The Innovation Space
+ 143 more
Shared employers
Also worked at Longwood Fund14
Rich AldrichFounding Partner at Longwood FundAleks Radovic-MorenoPartner at Longwood FundVikas GoyalPartner at Longwood FundRob HadfieldGeneral Counsel & Operating Partner at Longwood FundJohn McCabePortfolio Company CFO & COO at Longwood FundLucy LiuPrincipal at Longwood Fund
+ 8 more
Also worked at DEM Biopharma, Inc.6
John McCabePortfolio Company CFO & COO at Longwood FundSatoshi KonagaiInvestment Lead at Astellas Venture Management LLCDylan MorrisManaging Director at Insight PartnersAiden AcevesVice President at Insight PartnersMarie-Claire PeakmanExecutive Director, WWBD / Partner at Pfizer Venture InvestmentsChristophe QuevaExecutive Officer at Oncorus
Also worked at Apriori Bio2
Also worked at Flagship Pioneering105
Anika GuptaInvestor at GV (Google Ventures)Noubar AfeyanInvestor at Flagship PioneeringCassidy BlundellPartner at Mission BiocapitalDavid KoleskyPrincipal at MPM BioImpactDiana BernsteinDirector at Northpond VenturesInca ComanVenture Partner at ARCH Venture Partners
+ 99 more